Stockscreener 앱 받기
0.5352
68.35%
0.2173
시간 외 거래:
.53
-0.0052
-0.97%
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightChaikin Flow - dars.gov.et
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightAI Trade Signals - dars.gov.et
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightHigh Dividend Factor - dars.gov.et
Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge - TipRanks
Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Estrella Immunopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks
Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
ARMISTICE CAPITAL, LLC Reduces Stake in Estrella Immunopharma Inc (ESLA) by Nearly Half - GuruFocus
Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLong Short Pair - vinanet.vn
Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView
Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLow Risk Entry Stocks - dars.gov.et
Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionIchimoku TK Cross - vinanet.vn
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignInstitutional Buy Signals - vinanet.vn
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignTriangle Correction - siam.in
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignScalping Stock Signals - dars.gov.et
Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionFactor Rotation - dars.gov.et
Estrella Immunopharma Inc. (NASDAQ: ESLA) Share Price, ESLA Stock News, ESLA Share Price & Updates - kalkine.com.au
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSystematic Flow - vinanet.vn
Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake - Stock Titan
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatPost-Earnings Moves - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatFibonacci Fan - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSingle Stock ETF - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatLow Risk Entry Stocks - dars.gov.et
Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary - TradingView
Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace
Estrella adds fourth site to EB103 lymphoma trial - Investing.com
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance
Estrella Immunopharma Inc (ESLA) Stock News Today - TradingKey
Estrella Immunopharma (ESLA) Stock Price, News & Analysis - MarketBeat
Estrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Estrella Immunopharma (ESLA) Rallies 6.11% as CAR T-Cell Focus Draws Investor AttentionEarnings Sentiment - vinanet.vn
Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - tradingview.com
Estrella adds third site to EB103 lymphoma trial - Investing.com
Estrella adds third site to EB103 lymphoma trial By Investing.com - Investing.com South Africa
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Business Wire
Estrella Immunopharma (ESLA) Holds at $0.71 as Downside Pressures Remain ContainedTRIN Signal - dars.gov.et
Price to sales forward of Estrella Immunopharma, Inc. – BOATS:ESLAW - TradingView
Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView
Estrella Immunopharma (ESLA) Holds at $0.71 as Downside Pressures Remain ContainedTrend Following Picks - vinanet.vn
Estrella activates second site for EB103 lymphoma trial By Investing.com - Investing.com Canada
Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance
Estrella Immunopharma Inc (ESLA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Estrella Immunopharma Inc (ESLA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Estrella Immunopharma Inc (ESLA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Estrella Immunopharma Inc (ESLA) Balance Sheet - TradingKey
Estrella Immunopharma Inc (ESLA) Cash Flow - TradingKey
Estrella Immunopharma Inc (ESLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
1.35%
자본화:
|
볼륨(24시간):